Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Nov 2015. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
95547401000001113 | Tenofovir disoproxil + Efavirenz + Emtricitabine (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
106217301000001119 | Efavirenz + Emtricitabine + Tenofovir disoproxil | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Tenofovir disoproxil + Efavirenz + Emtricitabine | Is a | Product containing efavirenz and emtricitabine and tenofovir | true | Inferred relationship | Existential restriction modifier | ||
Tenofovir disoproxil + Efavirenz + Emtricitabine | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
Tenofovir disoproxil + Efavirenz + Emtricitabine | Has active ingredient | Tenofovir disoproxil fumarate | true | Inferred relationship | Existential restriction modifier | ||
Tenofovir disoproxil + Efavirenz + Emtricitabine | Has active ingredient | Efavirenz | true | Inferred relationship | Existential restriction modifier | ||
Tenofovir disoproxil + Efavirenz + Emtricitabine | Has active ingredient | Emtricitabine | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Generic Atripla 600mg/200mg/245mg tablets | Is a | True | Tenofovir disoproxil + Efavirenz + Emtricitabine | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets